U.S. market Closed. Opens in 1 day 4 hours 32 minutes

ENOV | Enovis Corporation Stock Overview

(Stock Exchange: NYSE)
Day's Range 42.02 - 43.59
52 Week Range 38.27 - 65.03
Beta 1.35
Implied Volatility 50.41%
IV Rank 48.60%
Day's Volume 631,750
Average Volume 650,046
Shares Outstanding 55,875,500
Market Cap 2,409,351,560
Sector Industrials
Industry Industrial - Machinery
IPO Date 2008-05-08
Valuation
Profitability
Growth
Health
P/E Ratio -19.51
Forward P/E Ratio N/A
EPS -2.21
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 6,550
Country USA
Website ENOV
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
ENOV's peers: HLIO, NPO, OFLX, LXFR, HURC, IEX, WTS, DCI, GRC, EPAC, MIDD, KAI, ITT, FELE, GHM
*Chart delayed
Analyzing fundamentals for ENOV we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is good and Health is weak. For more detailed analysis please see ENOV Fundamentals page.

Watching at ENOV technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ENOV Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙